Skip to main content
AI for Women's Health: A Policy Event
TalksFree

AI for Women's Health: A Policy Event

Ask AI: is it for me?

Similar events

View all →

About This Event

An event titled 'AI for Women's Health: A Policy Event' will take place at King's College, Cambridge on 9 November 2026. This policy-focused session will address the role of artificial intelligence in women's health, aiming to foster connections and identify future research areas. Attendance is free.

This policy-focused event explores the challenges and opportunities of artificial intelligence in women's health.

Organised by the AI for Women's Health Interest Group at the Alan Turing Institute and Teesside University in partnership with King's E-Lab, this session explores the challenges and opportunities of artificial intelligence in women's health. The event aims to foster new connections, surface emerging ideas, and identify future areas of research at the intersection of AI, women's health, and public policy.

Digital health technologies — from reproductive health tracking applications to diagnostic AI tools and large-scale health data platforms — are increasingly shaping healthcare and biomedical research. These developments offer significant opportunities to improve outcomes in areas historically under-researched in medicine, such as endometriosis and other reproductive health conditions, but also raise pressing questions about governance, equity, and patient trust.

Sessions and Speakers:

Dr Francesca Gaccioli an Assistant Research Professor in the Department of Obstetrics and Gynaecology at the University of Cambridge. Her research focuses on understanding placental pathophysiology and the underlying mechanisms driving pregnancy complications. Specifically, she investigates malfunctions arising from infectious etiologies, such as Group B Streptococcus, as well as multi-factorial conditions like preeclampsia and fetal growth restriction. Ultimately, her work aims to bridge the gap between placental biology and clinical obstetrics by identifying specific biomarkers and diagnostic tools for complex pregnancy diseases. Additionally, she is one of the founders of the FibroidsFREE Team, an advocacy initiative for uterine fibroids dedicated to elevating patient awareness and driving legislative reforms for equitable screening and treatment access.

Clarisa Lordache is the founder and president of Eu și Endometrioza Association, the oldest organization in Romania dedicated to raising awareness of endometriosis and adenomyosis. Diagnosed with both conditions 10 years ago, she transformed her experience as a patient into advocacy for change in health policy. She has represented patients from Romania in the European Parliament and the Romanian Parliament. She is the creator of the documentary Endodyssey, dedicated to the experiences of women living with endometriosis.

Dr. Roser Vento-Tormo joined the Wellcome Sanger Institute as an EMBO/HFSP postdoctoral fellow in the laboratory of Sarah Teichmann, after completing her PhD at the University of Barcelona. In 2019 she started her own group at the Wellcome Sanger Institute, dissecting the physiology of the poorly understood reproductive tissues across the lifespan. The cellular atlases of the female reproductive tissues generated by her team and released through the Human Cell Atlas are now widely across the field and have underpinned a series of fundamental discoveries. Her team identified previously unknown progenitors in reproductive tissues, including two epithelial progenitors that act in coordination to heal the endometrium (the mucosal lining of the uterus) after menstruation. In 2026 Roser was appointed Global Adjunct Principal Investigator at AITHYRA, the Vienna-based Institute for Biomedical Artificial Intelligence. Working with collaborators there, she is building a portfolio of predictive in silico models that infer phenotype from genotype. She has received numerous international awards, most recently the Foulkes Foundation Medal of the Academy of Medical Sciences (2025) and the Roger Valentine Short Medal and Lecture (2026); earlier recognition includes the Biochemical Society Early Career Research Award (2021) and Michelson Prize finalist (2023). Roser's lab (https://ventolab.org/) decodes the principles of tissue organisation, developing and integrating cutting-edge spatial genomics, artificial intelligence and gene editing tools to make tissue biology quantifiable and predictable. A major focus is how hormones shape cellular and tissue physiology in the female reproductive organs and other systems.

Please note that attendance at E-Lab events is strictly ticketed. All guests must have a valid ticket or registration for the event. Entry to King’s College remains at the discretion of the Porters, and registration for an event does not guarantee admission if College access requirements are not met.

Description supplied by the event organiser.

Staying overnight?

Hotels within walking distance of King's College, Cambridge.

Searching near King's Parade, Cambridge, CB2 1TL
Check-in: Monday, 9 November 2026
Find hotels near this venuecompare prices →

Ad · Stay22 affiliate link

Similar Events in Cambridge

View all →

More at King's College, Cambridge

View all →

Frequently asked questions

AI for Women's Health: A Policy Event takes place on Monday, 9 November 2026 at 09:30.

AI for Women's Health: A Policy Event is held at King's College, Cambridge in Cambridge (King's Parade, Cambridge, CB2 1TL).

Entry to AI for Women's Health: A Policy Event is free.

Yes — hotels within walking distance of King's College, Cambridge can be compared using the accommodation search further down this page.

Tickets for AI for Women's Health: A Policy Event can be booked via Eventbrite using the "Check Tickets & Live Prices" button on this page, which opens the official booking site in a new tab.

Price

Free Entry

Get Tickets